<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03696602</url>
  </required_header>
  <id_info>
    <org_study_id>enf4327</org_study_id>
    <nct_id>NCT03696602</nct_id>
  </id_info>
  <brief_title>More Relaxation by Deep Breath on Methacholine</brief_title>
  <acronym>SouProvocBro</acronym>
  <official_title>More Relaxation by Deep Breath on Methacholine- Than on Exercise-Induced Bronchoconstriction During the Routine Testing of Asthmatic Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Deep inhalation (DI) dilates normal airway precontracted with methacholine. The fact that&#xD;
      this effect is diminished or absent in asthma could be explained by the presence of bronchial&#xD;
      inflammation. The hypothesis tested was that DI induces more relaxation in methacholine&#xD;
      induced bronchoconstriction-solely determined by the smooth muscle contraction-than in&#xD;
      exercise induced bronchoconstriction, which is contributed to by both smooth muscle&#xD;
      contraction and airway wall inflammation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Children were referred to the lung function department by their pediatric pulmonologist.&#xD;
      Asthma was defined by a complaint of wheezing, cough, dyspnoea or chest tightness at rest or&#xD;
      on exercising and a positive response to methacholine or exercise challenge.&#xD;
&#xD;
      The response to exercise was considered positive when Forced Expiratory Volume in 1 s (FEV1)&#xD;
      decreased at least 8% from Baseline.&#xD;
&#xD;
      The response to methacholine was considered positive when FEV1 decreased at least 20% or Rrs&#xD;
      increased at least 50% from baseline, at or below a cumulated dose of 1,200 Î¼g.&#xD;
&#xD;
      Bronchodilator medications were discontinued at least 12 hours prior to the testing and&#xD;
      provocation allowed when the child had been free of respiratory symptoms for at least 2 weeks&#xD;
      and baseline FEV1 was larger than 70% pred. Exercise and methacholine groups were matched for&#xD;
      age, height, baseline FEV1 z-score, a moderate level of airway response to challenge and DI&#xD;
      amplitude ranging 40-60% of the predicted Forced Vital Capacity (FVC). Written informed&#xD;
      consent was obtained from the children and their parents for the procedures. Procedures for&#xD;
      spirometry, exhaled fraction of NO (FENO), GrsDI (Respiratory conductance response to a deep&#xD;
      inhalation) and challenges have been described previously. Acceptable GrsDI's were analyzed&#xD;
      at a 10-20% FEV1 decrease from baseline. Statistics were performed using Mann-Whitney, Chi&#xD;
      square tests and multiple regression as required. Data are median and interquartile range.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2006</start_date>
  <completion_date type="Actual">September 30, 2016</completion_date>
  <primary_completion_date type="Actual">June 30, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Grs change between before deep breath and after deep breath in exercise and metacholine groups</measure>
    <time_frame>through study completion, an average of 1 hour</time_frame>
    <description>GrsDI represents Grs measured after deep breath reported to Grs before deep breath (bronchial provocation test)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">78</enrollment>
  <condition>Childhood Asthma</condition>
  <arm_group>
    <arm_group_label>test with methacholine</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>test with exercise</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>bronchial provocation test</intervention_name>
    <arm_group_label>test with exercise</arm_group_label>
    <arm_group_label>test with methacholine</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Seventy-three asthmatic children (48 boys) were selected, 37 underwent exercise challenge&#xD;
        and 36 methacholine.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Children referred to the lung function department by their pediatric pulmonologist.&#xD;
&#xD;
          -  Asthma defined by a complaint of wheezing, cough and dyspnoea.&#xD;
&#xD;
          -  Positive response to methacholine or exercise challenge.&#xD;
&#xD;
          -  Bronchodilator medications discontinued at least 12 h prior to the testing&#xD;
&#xD;
          -  Provocation allowed when the child had been free of respiratory symptoms for at least&#xD;
             2 weeks and baseline FEV1 larger than 70% pred.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Other respiratory diseases than asthma&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 21, 2018</study_first_submitted>
  <study_first_submitted_qc>September 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 4, 2018</study_first_posted>
  <last_update_submitted>September 28, 2018</last_update_submitted>
  <last_update_submitted_qc>September 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>airway smooth muscle, asthma, bronchial test, lung function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

